SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CAMPO, Gianluca Calogero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.426
AS - Asia 5.907
EU - Europa 5.360
SA - Sud America 600
AF - Africa 57
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 6
Totale 29.394
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.299
SG - Singapore 2.864
CN - Cina 1.743
IT - Italia 1.287
DE - Germania 1.176
UA - Ucraina 615
FI - Finlandia 566
BR - Brasile 524
TR - Turchia 505
GB - Regno Unito 464
ID - Indonesia 301
PL - Polonia 296
SE - Svezia 279
FR - Francia 141
CA - Canada 108
NL - Olanda 102
BE - Belgio 93
HK - Hong Kong 88
VN - Vietnam 82
IN - India 70
AT - Austria 64
RU - Federazione Russa 44
LT - Lituania 39
CZ - Repubblica Ceca 38
KR - Corea 35
AU - Australia 34
EG - Egitto 24
JP - Giappone 24
ES - Italia 23
CH - Svizzera 21
IQ - Iraq 20
IR - Iran 20
PK - Pakistan 20
IE - Irlanda 18
CO - Colombia 16
AR - Argentina 14
BD - Bangladesh 14
DK - Danimarca 14
MY - Malesia 13
UZ - Uzbekistan 13
PT - Portogallo 12
EC - Ecuador 10
TH - Thailandia 10
TW - Taiwan 10
CL - Cile 9
MX - Messico 9
RO - Romania 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
PE - Perù 7
PY - Paraguay 7
ZA - Sudafrica 7
JO - Giordania 6
KE - Kenya 6
KG - Kirghizistan 6
MA - Marocco 6
RS - Serbia 6
AL - Albania 5
CY - Cipro 5
HU - Ungheria 5
IL - Israele 5
JM - Giamaica 5
MK - Macedonia 5
NP - Nepal 5
PH - Filippine 5
SA - Arabia Saudita 5
SK - Slovacchia (Repubblica Slovacca) 5
BG - Bulgaria 4
EU - Europa 4
HR - Croazia 4
LI - Liechtenstein 4
MD - Moldavia 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
DZ - Algeria 3
LB - Libano 3
LK - Sri Lanka 3
LU - Lussemburgo 3
PA - Panama 3
TN - Tunisia 3
UY - Uruguay 3
BN - Brunei Darussalam 2
BQ - ???statistics.table.value.countryCode.BQ??? 2
GR - Grecia 2
IM - Isola di Man 2
KZ - Kazakistan 2
LV - Lettonia 2
PS - Palestinian Territory 2
QA - Qatar 2
SI - Slovenia 2
SN - Senegal 2
TJ - Tagikistan 2
TM - Turkmenistan 2
AM - Armenia 1
AO - Angola 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
Totale 29.383
Salva come PNG Salva come JPEG
Città #
Fairfield 2.306
Woodbridge 1.817
Ashburn 1.321
Santa Clara 1.288
Singapore 1.287
Houston 1.176
Chandler 1.034
Seattle 945
Wilmington 851
Ann Arbor 809
Cambridge 767
Jacksonville 758
Munich 573
Helsinki 387
Izmir 340
Beijing 327
Princeton 325
Warsaw 286
Jakarta 275
Nanjing 270
Ferrara 266
New York 262
Shanghai 260
San Diego 206
Milan 202
Los Angeles 137
Boardman 134
London 104
Bologna 93
Brussels 91
Bremen 80
Shenyang 74
Nanchang 72
Hong Kong 64
Nuremberg 64
Redwood City 64
Falls Church 63
Falkenstein 53
Frankfurt am Main 53
Toronto 53
Jiaxing 52
Tianjin 52
Washington 50
Mountain View 44
Changsha 41
São Paulo 41
Hebei 40
Dong Ket 39
Addison 34
Ottawa 34
San Mateo 34
Norwalk 32
Rome 30
Lappeenranta 29
Jinan 28
Chicago 27
Brno 24
Des Moines 24
Jyväskylä 24
Kunming 23
Orange 22
Augusta 21
Guangzhou 21
Rio de Janeiro 21
Ningbo 20
Redmond 20
Vienna 20
Council Bluffs 19
Zhengzhou 19
Melbourne 16
Rimini 16
Tappahannock 16
Amsterdam 15
Auburn Hills 15
Belo Horizonte 15
Dearborn 15
Mumbai 15
Dublin 13
Taizhou 13
Tokyo 13
Atlanta 12
Hangzhou 12
Leawood 12
Monmouth Junction 12
Napoli 12
Baghdad 10
Hounslow 10
Indiana 10
Kilburn 10
Moscow 10
Tashkent 10
Zurich 10
Florence 9
Lugo 9
Naples 9
Bangkok 8
Betim 8
Cairo 8
Chennai 8
Ferrara di Monte Baldo 8
Totale 20.781
Salva come PNG Salva come JPEG
Nome #
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology 319
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 282
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial 281
Effectiveness and safety of the ABSORB bioresorbable vascular scaffold for the treatment of coronary artery disease: Systematic review and meta-analysis of randomized clinical trials 272
Exercise Intervention to Improve Functional Capacity in Older Adults After Acute Coronary Syndrome 209
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 208
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study 207
How the functional assessment of culprit and non-culprit lesions may improve stratification and treatment of STEMI patients 187
Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation 182
Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury 181
Atrial Longitudinal Strain Predicts New-Onset Atrial Fibrillation: A Systematic Review and Meta-Analysis 179
Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study) 177
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 177
Diagnostic accuracy of baseline troponin and troponin change for the diagnosis of myocardial infarction complicated with heart failure 165
Prospective identification of stent fracture by enhanced stent visualization system during percutaneous coronary intervention 163
The use of nutraceuticals to counteract atherosclerosis: The role of the Notch pathway 160
Translating Evidence from Clonal Hematopoiesis to Cardiovascular Disease: A Systematic Review 158
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 156
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 156
Poor response to clopidogrel: current and future options for its management 156
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 155
Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F1/FO-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction 154
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study 153
SERPINA1 Gene Promoter Is Differentially Methylated in Peripheral Blood Mononuclear Cells of Pregnant Women 153
Kounis-Zavras syndrome presenting with ventricular arrhythmias and cardiogenic shock 151
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 150
Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. 148
Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention 146
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 146
Short Physical Performance Battery and all-cause mortality: Systematic review and meta-analysis 146
Mechanistic role of mPTP in ischemia-reperfusion injury 145
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 143
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 143
Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial 142
Notch Signaling Regulates Immune Responses in Atherosclerosis 142
Fractional flow reserve: Current applications and overview of the available data 141
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) 139
Tailored Medical and Interventional Therapy Against Recurrent Stent Thrombosis After Drug-Eluting Stenting 137
Can we improve myocardial protection during ischaemic injury? 137
Ticagrelor improves endothelial function by decreasing circulating Epidermal Growth Factor (EGF) 136
Reperfusion Damage - A Story of Success, Failure, and Hope 135
Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial 135
The Mitochondrial Permeability Transition Pore 135
Characterization of Dermal Stem Cells of Diabetic Patients 135
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 134
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes 133
Prognostic Impact of Hospital Readmissions After Primary Percutaneous Coronary Intervention 132
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease 132
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes (Am Journal of Cardiovasc Drugs (2011) 11:3 (189-98)) 131
The in vitro effects of verbascoside on human platelet aggregation 131
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 131
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials 131
1,3,8-Triazaspiro[4.5]decane Derivatives Inhibit Permeability Transition Pores through a FO-ATP Synthase c Subunit Glu119-Independent Mechanism That Prevents Oligomycin A-Related Side Effects 130
Grip strength predicts cardiac adverse events in patients with cardiac disorders: An individual patient pooled meta-analysis 130
Nutritional status and all-cause mortality in older adults with acute coronary syndrome 130
A Patient-Level Pooled Analysis Assessing the Impact of the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) Score on 1-Year Clinical Outcomes in 6,508 Patients Enrolled in Contemporary Coronary Stent Trials 130
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 129
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention 129
C subunit of F1/FO-ATP synthase as target for preventing the detrimental effect of myocardial ischemia/reperfusion injury 129
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting 128
Bleeding Risk Scores and Scales of Frailty for the Prediction of Haemorrhagic Events in Older Adults with Acute Coronary Syndrome: Insights from the FRASER study 126
Patient selection to enhance the long-term benefit of first generation drug-eluting stents for coronary revascularisation procedures. Insights from a large multicentre registry 126
CHA2DS2-VASc risk factors as predictors of stroke after acute coronary syndrome: A systematic review and meta-analysis 125
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 124
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 124
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 123
Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trial 123
Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial 122
Impact of a recent hospitalization on treatment and prognosis of ST-segment elevation myocardial infarction 122
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: Results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel study 121
Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates 121
Context-dependent function of ROS in the vascular endothelium: The role of the Notch pathway and shear stress 121
BRS implantation in long lesions requiring device overlapping: Myth or reality? 121
Impact of COPD on Long-term Outcome After ST-Segment Elevation Myocardial Infarction Receiving Primary Percutaneous Coronary Intervention 121
Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry 119
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 118
Fractional flow reserve implementation in daily clinical practice: A European survey 118
A Strategy to offset the extra cost of sirolimus-eluting stent in patients undergoing intervention for acute myocardial infarction. 117
Long-term clinical outcomes and cost-effectiveness analysis in multivessel percutaneous coronary interventions: comparison of drug-eluting stents, bare-metal stents and a mixed approach in patients at high and low risk of repeat revascularisation. 117
Relevance of gender in patients with acute myocardial infarction undergoing coronary interventions 117
Antithrombotic management and 1-year outcome of patients on oral anticoagulation undergoing coronary stent implantation (from the registro regionale angioplastiche Emilia-Romagna registry) 117
Meta-Analysis of the Duration of Dual Antiplatelet Therapy in Patients Treated with Second-Generation Drug-Eluting Stents 117
Specific properties and effect of perindopril in controlling the renin-angiotensin system. 116
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study 116
Diagnostic performance of in-procedure angiography-derived quantitative flow reserve compared to pressure-derived fractional flow reserve: The FAVOR II Europe-Japan study 115
Different clinical models of CD34 plus cells mobilization in patients with cardiovascular disease 114
Randomized comparison of Zotarolimus-Eluting Endeavor Sprint versus bare-metal stent implantation in uncertain drug-eluting stent candidates: Rationale, design, and characterization of the patient population for the Zotarolimus-eluting Endeavor Sprint stent in Uncertain DES Candidates study 114
Poor responsiveness to clopidogrel. Drug-specific or class-effect? 114
Operator, Drug or Device: Who Will Break Down Acute Stent Thrombosis 114
Long-term outcomes with cobalt-chromium bare-metal vs. drug-eluting stents: the REgistro regionale AngiopLastiche dell'Emilia-Romagna registry 114
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 113
Role of the tricuspid regurgitation after mitraclip and transcatheter aortic valve implantation: A systematic review and meta-analysis 113
Coagulation factors and recurrence of ischemic and bleeding adverse events in patients with acute coronary syndromes 111
A Prospective Evaluation of a Standardized Strategy for the Use of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in ST-Segment Elevation Myocardial Infarction: Rationale and Design of the BVS STEMI STRATEGY-IT Study 111
Impact of culprit plaque and atherothrombotic components on incomplete stent apposition in patients with ST-elevation myocardial infarction treated with Everolimus-eluting stents-an OCTAVIA Substudy 111
Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials. 110
Dual Antiplatelet Therapy in Patients with Glucose-6-Phosphate Dehydrogenase Deficiency undergoing PCI with Drug-Eluting Stents. 110
CHA2DS2-VASc score predicts atrial fibrillation recurrence after cardioversion: systematic review and individual patient pooled meta-analysis 110
Same-day transfer for the invasive strategy of patients with non-ST-segment elevation acute coronary syndrome admitted to spoke hospitals: Data from the Emilia-Romagna Regional Network 109
Incidence and outcome of high on-treatment platelet reactivity in patients with non-st elevation acute coronary syndromes undergoing percutaneous coronary intervention (from the VIP [verifynow and inhibition of platelet reactivity] study) 109
Totale 14.196
Salva come PNG Salva come JPEG
Categoria #
all - tutte 196.472
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.448
Totale 197.920
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.223 0 0 0 0 0 0 0 0 433 435 225 130
2020/20213.841 198 262 194 489 231 300 166 498 174 541 536 252
2021/20223.161 274 287 207 148 146 163 193 195 142 239 337 830
2022/20232.784 340 126 141 235 406 396 177 251 360 71 191 90
2023/20242.794 169 292 130 91 214 490 132 281 68 128 142 657
2024/20258.355 313 330 920 586 1.425 1.211 806 708 2.056 0 0 0
Totale 30.431